Serum heat shock protein 70 levels and lung cancer risk

A case-control study nested in a large cohort study

Koji Suzuki, Yoshinori Ito, Kenji Wakai, Miyuki Kawado, Shuji Hashimoto, Nao Seki, Masahiko Ando, Yoshikazu Nishino, Takaaki Kondo, Yoshiyuki Watanabe, Kotaro Ozasa, Takashi Inoue, Akiko Tamakoshi

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Chronic inflammation contributes to the process of carcinogenesis, but few epidemiologic studies have examined associations with risk of lung cancer. Relationships between lung cancer risk and serum levels of both heat shock protein 70 (Hsp70) and high-sensitivity C-reactive protein (hsCRP) were investigated in a case-control study nested in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. Serum samples and lifestyle information were collected at baseline from 39,242 men and women between 1988 and 1990. Of these, 240 deaths from lung cancer were identified through 1999, and 569 controls were matched for sex, age, and study area. Serum levels were measured in 189 cases and 377 controls for Hsp70 and in 209 cases and 425 controls for hsCRP. Odds ratios (95% confidence intervals) across quartiles, adjusted for confounding factors, including smoking habits, were 0.83 (0.44-1.58), 1.41 (0.77-2.60), and 1.84 (0.92-3.71) for Hsp70 (Ptrend = 0.042) and 1.13 (0.67-1.91), 0.66 (0.38-1.16), and 1.19 (0.70-2.02) for hsCRP (P trend = 0.941). In males, odds ratios (95% confidence intervals) across quartiles were 1.30 (0.59-2.84), 1.74 (0.83-3.67), and 2.49 (1.06-5.85) for Hsp70 (Ptrend = 0.029). High levels of serum Hsp70 might thus be associated with increased risk of lung cancer among Japanese males, although further studies are needed to clarify associations between chronic inflammation and lung cancer.

Original languageEnglish
Pages (from-to)1733-1737
Number of pages5
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number9
DOIs
Publication statusPublished - 01-09-2006

Fingerprint

HSP70 Heat-Shock Proteins
Case-Control Studies
Blood Proteins
Lung Neoplasms
Cohort Studies
C-Reactive Protein
Serum
Odds Ratio
Confidence Intervals
Inflammation
Habits
Life Style
Epidemiologic Studies
Japan
Carcinogenesis
Smoking
Neoplasms

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology

Cite this

Suzuki, Koji ; Ito, Yoshinori ; Wakai, Kenji ; Kawado, Miyuki ; Hashimoto, Shuji ; Seki, Nao ; Ando, Masahiko ; Nishino, Yoshikazu ; Kondo, Takaaki ; Watanabe, Yoshiyuki ; Ozasa, Kotaro ; Inoue, Takashi ; Tamakoshi, Akiko. / Serum heat shock protein 70 levels and lung cancer risk : A case-control study nested in a large cohort study. In: Cancer Epidemiology Biomarkers and Prevention. 2006 ; Vol. 15, No. 9. pp. 1733-1737.
@article{23f0fe4525e54769b8761e095d6153eb,
title = "Serum heat shock protein 70 levels and lung cancer risk: A case-control study nested in a large cohort study",
abstract = "Chronic inflammation contributes to the process of carcinogenesis, but few epidemiologic studies have examined associations with risk of lung cancer. Relationships between lung cancer risk and serum levels of both heat shock protein 70 (Hsp70) and high-sensitivity C-reactive protein (hsCRP) were investigated in a case-control study nested in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. Serum samples and lifestyle information were collected at baseline from 39,242 men and women between 1988 and 1990. Of these, 240 deaths from lung cancer were identified through 1999, and 569 controls were matched for sex, age, and study area. Serum levels were measured in 189 cases and 377 controls for Hsp70 and in 209 cases and 425 controls for hsCRP. Odds ratios (95{\%} confidence intervals) across quartiles, adjusted for confounding factors, including smoking habits, were 0.83 (0.44-1.58), 1.41 (0.77-2.60), and 1.84 (0.92-3.71) for Hsp70 (Ptrend = 0.042) and 1.13 (0.67-1.91), 0.66 (0.38-1.16), and 1.19 (0.70-2.02) for hsCRP (P trend = 0.941). In males, odds ratios (95{\%} confidence intervals) across quartiles were 1.30 (0.59-2.84), 1.74 (0.83-3.67), and 2.49 (1.06-5.85) for Hsp70 (Ptrend = 0.029). High levels of serum Hsp70 might thus be associated with increased risk of lung cancer among Japanese males, although further studies are needed to clarify associations between chronic inflammation and lung cancer.",
author = "Koji Suzuki and Yoshinori Ito and Kenji Wakai and Miyuki Kawado and Shuji Hashimoto and Nao Seki and Masahiko Ando and Yoshikazu Nishino and Takaaki Kondo and Yoshiyuki Watanabe and Kotaro Ozasa and Takashi Inoue and Akiko Tamakoshi",
year = "2006",
month = "9",
day = "1",
doi = "10.1158/1055-9965.EPI-06-0005",
language = "English",
volume = "15",
pages = "1733--1737",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

Suzuki, K, Ito, Y, Wakai, K, Kawado, M, Hashimoto, S, Seki, N, Ando, M, Nishino, Y, Kondo, T, Watanabe, Y, Ozasa, K, Inoue, T & Tamakoshi, A 2006, 'Serum heat shock protein 70 levels and lung cancer risk: A case-control study nested in a large cohort study', Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 9, pp. 1733-1737. https://doi.org/10.1158/1055-9965.EPI-06-0005

Serum heat shock protein 70 levels and lung cancer risk : A case-control study nested in a large cohort study. / Suzuki, Koji; Ito, Yoshinori; Wakai, Kenji; Kawado, Miyuki; Hashimoto, Shuji; Seki, Nao; Ando, Masahiko; Nishino, Yoshikazu; Kondo, Takaaki; Watanabe, Yoshiyuki; Ozasa, Kotaro; Inoue, Takashi; Tamakoshi, Akiko.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 15, No. 9, 01.09.2006, p. 1733-1737.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum heat shock protein 70 levels and lung cancer risk

T2 - A case-control study nested in a large cohort study

AU - Suzuki, Koji

AU - Ito, Yoshinori

AU - Wakai, Kenji

AU - Kawado, Miyuki

AU - Hashimoto, Shuji

AU - Seki, Nao

AU - Ando, Masahiko

AU - Nishino, Yoshikazu

AU - Kondo, Takaaki

AU - Watanabe, Yoshiyuki

AU - Ozasa, Kotaro

AU - Inoue, Takashi

AU - Tamakoshi, Akiko

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Chronic inflammation contributes to the process of carcinogenesis, but few epidemiologic studies have examined associations with risk of lung cancer. Relationships between lung cancer risk and serum levels of both heat shock protein 70 (Hsp70) and high-sensitivity C-reactive protein (hsCRP) were investigated in a case-control study nested in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. Serum samples and lifestyle information were collected at baseline from 39,242 men and women between 1988 and 1990. Of these, 240 deaths from lung cancer were identified through 1999, and 569 controls were matched for sex, age, and study area. Serum levels were measured in 189 cases and 377 controls for Hsp70 and in 209 cases and 425 controls for hsCRP. Odds ratios (95% confidence intervals) across quartiles, adjusted for confounding factors, including smoking habits, were 0.83 (0.44-1.58), 1.41 (0.77-2.60), and 1.84 (0.92-3.71) for Hsp70 (Ptrend = 0.042) and 1.13 (0.67-1.91), 0.66 (0.38-1.16), and 1.19 (0.70-2.02) for hsCRP (P trend = 0.941). In males, odds ratios (95% confidence intervals) across quartiles were 1.30 (0.59-2.84), 1.74 (0.83-3.67), and 2.49 (1.06-5.85) for Hsp70 (Ptrend = 0.029). High levels of serum Hsp70 might thus be associated with increased risk of lung cancer among Japanese males, although further studies are needed to clarify associations between chronic inflammation and lung cancer.

AB - Chronic inflammation contributes to the process of carcinogenesis, but few epidemiologic studies have examined associations with risk of lung cancer. Relationships between lung cancer risk and serum levels of both heat shock protein 70 (Hsp70) and high-sensitivity C-reactive protein (hsCRP) were investigated in a case-control study nested in the Japan Collaborative Cohort Study for Evaluation of Cancer Risk. Serum samples and lifestyle information were collected at baseline from 39,242 men and women between 1988 and 1990. Of these, 240 deaths from lung cancer were identified through 1999, and 569 controls were matched for sex, age, and study area. Serum levels were measured in 189 cases and 377 controls for Hsp70 and in 209 cases and 425 controls for hsCRP. Odds ratios (95% confidence intervals) across quartiles, adjusted for confounding factors, including smoking habits, were 0.83 (0.44-1.58), 1.41 (0.77-2.60), and 1.84 (0.92-3.71) for Hsp70 (Ptrend = 0.042) and 1.13 (0.67-1.91), 0.66 (0.38-1.16), and 1.19 (0.70-2.02) for hsCRP (P trend = 0.941). In males, odds ratios (95% confidence intervals) across quartiles were 1.30 (0.59-2.84), 1.74 (0.83-3.67), and 2.49 (1.06-5.85) for Hsp70 (Ptrend = 0.029). High levels of serum Hsp70 might thus be associated with increased risk of lung cancer among Japanese males, although further studies are needed to clarify associations between chronic inflammation and lung cancer.

UR - http://www.scopus.com/inward/record.url?scp=33749356559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749356559&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-06-0005

DO - 10.1158/1055-9965.EPI-06-0005

M3 - Article

VL - 15

SP - 1733

EP - 1737

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -